ATE217193T1 - Verwendung von spezifischen rxr-rezeptorliganden - Google Patents

Verwendung von spezifischen rxr-rezeptorliganden

Info

Publication number
ATE217193T1
ATE217193T1 AT96401140T AT96401140T ATE217193T1 AT E217193 T1 ATE217193 T1 AT E217193T1 AT 96401140 T AT96401140 T AT 96401140T AT 96401140 T AT96401140 T AT 96401140T AT E217193 T1 ATE217193 T1 AT E217193T1
Authority
AT
Austria
Prior art keywords
specific
ligand
receptor ligands
rxr receptor
specific rxr
Prior art date
Application number
AT96401140T
Other languages
English (en)
Inventor
Michel Demarchez
Andre Jomard
Original Assignee
Galderma Rech Dermatologique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Rech Dermatologique filed Critical Galderma Rech Dermatologique
Application granted granted Critical
Publication of ATE217193T1 publication Critical patent/ATE217193T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT96401140T 1995-06-19 1996-05-28 Verwendung von spezifischen rxr-rezeptorliganden ATE217193T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9507300A FR2735367B1 (fr) 1995-06-19 1995-06-19 Utilisation de ligands specifiques des recepteurs rxrs

Publications (1)

Publication Number Publication Date
ATE217193T1 true ATE217193T1 (de) 2002-05-15

Family

ID=9480139

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96401140T ATE217193T1 (de) 1995-06-19 1996-05-28 Verwendung von spezifischen rxr-rezeptorliganden

Country Status (11)

Country Link
US (1) US6004987A (de)
EP (1) EP0749752B1 (de)
JP (1) JP2804014B2 (de)
AT (1) ATE217193T1 (de)
AU (1) AU688216B2 (de)
CA (1) CA2179426A1 (de)
DE (1) DE69621076T2 (de)
DK (1) DK0749752T3 (de)
ES (1) ES2179168T3 (de)
FR (1) FR2735367B1 (de)
PT (1) PT749752E (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753091B1 (fr) * 1996-09-09 2001-03-16 Oreal Utilisation d'un agoniste des recepteurs des retinoides de type rxr pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
PL334840A1 (en) * 1997-01-24 2000-03-27 Univ California Application of fxr, pparalpha and lxralpha activators in order to restore the barrier function, to stimulate epithelium differentation and to inhibit proliferation
BR9808866A (pt) * 1997-04-11 2000-08-01 Sidney Kimmel Cancer Ct Moléculas retinóicas relacionadas à inibição da superprodução de endotelina-1 em doenças
FR2767058B1 (fr) * 1997-08-05 2000-05-05 Centre Nat Rech Scient Utilisation d'un compose de type retinoide, notamment l'acide retinoique pour la preparation d' un medicament destine au traitement de l'obesite.
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
EP0908179A1 (de) * 1997-08-23 1999-04-14 Werner Bollag Behandlung von zellvermittelten Immunkrankheiten
BR9909599A (pt) * 1998-05-06 2001-09-25 Galderma Res & Dev Método cosmético, dermatológico e/ou terapêutico para alterar (promover ou inibir) a pigmentação da pele e/ou dos cabelos de um ser humano, composição farmacêutica/cosmética/dermatológica que altera a pigmentação da pele e/ou dos cabelos humanos com aplicação tópica e método in vitro para selecionar composto ou combinação de composto que alteram (aumentam ou diminuem) a pigmentação da pele e/ou dos cabelos humanos
US20030113281A1 (en) * 1998-05-06 2003-06-19 Galderma Research & Development, S.N.C. Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay
US6525094B1 (en) * 1999-06-01 2003-02-25 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylether derivatives
US6723717B1 (en) 1999-06-01 2004-04-20 The University Of Texas Southwestern Medical Center Sulfur-containing thyroxane derivatives and their use as hair growth promotors
AU3712100A (en) 1999-06-01 2000-12-18 University Of Texas Southwestern Medical Center, The Method of treating hair loss using sulfonyl thyromimetic compounds
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
MXPA01012495A (es) * 1999-06-01 2003-09-10 Univ Texas Southwestern Med Ct Metodo para tratar la perdida capilar con el uso de derivados de difenilmetano.
US6436993B1 (en) * 1999-07-13 2002-08-20 The Salk Institute For Biological Studies Use of RAR antagonists as modulators of hormone mediated processes
US20060079490A1 (en) * 2001-01-25 2006-04-13 Deluca Hector F Method of treatment of type I diabetes
US20030018017A1 (en) * 2001-01-25 2003-01-23 Deluca Hector F. Method of treatment of type I diabetes
JP4473491B2 (ja) * 2002-05-28 2010-06-02 株式会社資生堂 毛穴縮小剤
JP2004020220A (ja) * 2002-06-12 2004-01-22 Pioneer Electronic Corp 通信システム及び方法、通信端末装置、通信センタ装置、並びにコンピュータプログラム
US20050202055A1 (en) 2004-03-11 2005-09-15 Koichi Shudo, Tokyo, Japan Anti-wrinkle agent
CN101316584A (zh) * 2005-09-27 2008-12-03 北海道公立大学法人札幌医科大学 用于预防及治疗由血管通透性亢进引起的眼病的医药

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015901A1 (en) * 1993-01-11 1994-07-21 Ligand Pharmaceuticals Inc. Compounds having selectivity for retinoid x receptors
DK0678087T3 (da) * 1993-01-11 1999-09-27 Ligand Pharm Inc Forbindelser med selektiv aktivitet til retinoid-X-receptorer og metoder til modulering af processer medieret af retinoid-X
US5455265A (en) * 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
FR2722985B1 (fr) * 1994-07-27 1996-09-13 Cird Galderma Nouvelles compositions a base d'un melange synergetique entre au moins un ligand specifique des rxrs et au moins un ligand specifique de rar-x ou de vdr, et leurs utilisations

Also Published As

Publication number Publication date
JP2804014B2 (ja) 1998-09-24
AU688216B2 (en) 1998-03-05
FR2735367B1 (fr) 1997-07-18
DE69621076T2 (de) 2002-08-29
ES2179168T3 (es) 2003-01-16
AU5470396A (en) 1997-01-16
EP0749752A1 (de) 1996-12-27
CA2179426A1 (fr) 1996-12-20
PT749752E (pt) 2002-08-30
EP0749752B1 (de) 2002-05-08
FR2735367A1 (fr) 1996-12-20
DK0749752T3 (da) 2002-08-26
DE69621076D1 (de) 2002-06-13
JPH092972A (ja) 1997-01-07
US6004987A (en) 1999-12-21

Similar Documents

Publication Publication Date Title
DE69621076D1 (de) Verwendung von spezifischen RXR-Rezeptorliganden
DE69535095D1 (de) Vorrichtung zum austeilen von gebrauchsfertiger visköser lösung sowie deren verwendung zum austeilen
DE69123604T2 (de) Elektrophoretische anzeigetafel unter verwendung von graustufenfähigkeit mit flächenmodulation
DE3775586D1 (de) Bituminoese zusammensetzung und ihre verwendung als kalt auftrabarer haftklebstoff.
DE3580979D1 (de) Vorrichtung zum regeln von helligkeit und kontrast.
DE69525160D1 (de) Cursorführungsvorrichtung unter Verwendung von Dünnfilm-Interferenzfiltern
ATE55730T1 (de) Druckempfindliches aufzeichnungsmaterial.
NO933860D0 (no) Ekstracellulaere matriks-reseptorligander som modulerer leukocyttfunksjon
NO870923D0 (no) Apparat for styring av lasthaandteringsposisjon.
DE69000466D1 (de) Steuern von teilchenmaterial.
DE3686922T2 (de) Ablenkungsschaltung mit modulatorschaltung mit schaltmodus.
DE69500085T2 (de) Synergistische Mischung mindestens eines RXR-spezifischen Liganden mit mindestenseinem RAR-Alpha spezifischen Liganden
SE9904586L (sv) Sätt vid bestrykning av en löpande bana samt anordning
DE69308302D1 (de) Klebstoffe für das beschichten von zahlreichen substraten mit vinyl
ATE220692T1 (de) Katalysatorzubereitung für die (co)polymerisation von alk-1-enen
DE69610384D1 (de) Fotopolymerisierbare Zusammensetzung und fotographische Druckplatte unter Verwendung derselben
DE29716803U1 (de) Vorrichtung zum Beschichten von Teilen mit flüssigen, pastösen, thixotropen und faser- oder partikelhaltigen Stoffen
DE68919786T2 (de) Geruchlose von polyvalenten Metallen modifizierte Salizylsäurecopolymere, deren Herstellungsverfahren und ihre Verwendung als Farbentwicklungsmittel für druckempfindliche Aufzeichnungspapierschichten.
DE69007931D1 (de) Akarizide zusammensetzung und ihre verwendung in der befallsbekämpfung.
DE3882967D1 (de) Verfahren zum steuern von einem anzeigegeraet mit flachem bildschirm und anzeigegeraet mit flachem bildschirm.
DE3688448T2 (de) Elimination von feldinduzierten instabilitäten in elektrooptischen modulatoren.
FR2561072B1 (fr) Dispositif de distribution de matieres pateuses
KR880701800A (ko) 직물상 웨브를 적어도 하나의 필름으로 피복시키는 방법 그 필름의 출발물질들의 배합, 이에 따른 제품 및 이의 용도
DE68905998D1 (de) Modulationsart mit linearen phasenspruengen und konstanter umhuellung.
AU581294B2 (en) Plate web girder

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee